Hybio Pharmaceutical (300199) — Cash Flow Reinvestment Rate
Hybio Pharmaceutical (300199) has a Cash Flow Reinvestment Rate of 0.81x as of September 2025, reinvesting CN¥95.60 Million (capex CN¥95.60 Million ) from operating cash flow of CN¥117.78 Million. Check 300199 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hybio Pharmaceutical Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Hybio Pharmaceutical across 17 annual periods. Explore 300199 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hybio Pharmaceutical (2007–2024)
Year-by-year capital reinvestment analysis for Hybio Pharmaceutical. For live market cap and broader valuation context, see Hybio Pharmaceutical stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥116.14 Million | CN¥164.71 Million | CN¥115.84 Million | ▼ -97.1% |
| 2022 | 24.36x | CN¥385.14 Million | CN¥15.81 Million | CN¥189.85 Million | ▲ +1635.3% |
| 2021 | 1.40x | CN¥220.20 Million | CN¥156.83 Million | CN¥199.00 Million | ▼ -73.9% |
| 2020 | 5.39x | CN¥258.66 Million | CN¥47.99 Million | CN¥243.66 Million | ▼ -7.0% |
| 2019 | 5.80x | CN¥606.40 Million | CN¥104.64 Million | CN¥570.15 Million | ▼ -36.0% |
| 2018 | 9.06x | CN¥425.58 Million | CN¥47.00 Million | CN¥365.58 Million | ▲ +771.3% |
| 2017 | 1.04x | CN¥222.14 Million | CN¥213.74 Million | CN¥221.14 Million | ▲ +133.7% |
| 2016 | 0.44x | CN¥131.80 Million | CN¥296.41 Million | CN¥116.05 Million | ▼ -94.5% |
| 2015 | 8.09x | CN¥1.12 Billion | CN¥138.84 Million | CN¥358.98 Million | ▲ +1358.1% |
| 2014 | 0.56x | CN¥85.16 Million | CN¥153.43 Million | CN¥85.16 Million | ▼ -71.9% |
| 2013 | 1.97x | CN¥302.85 Million | CN¥153.48 Million | CN¥302.85 Million | ▼ -22.3% |
| 2012 | 2.54x | CN¥221.38 Million | CN¥87.19 Million | CN¥221.38 Million | ▲ +135.1% |
| 2011 | 1.08x | CN¥78.27 Million | CN¥72.48 Million | CN¥78.27 Million | ▲ +158.8% |
| 2010 | 0.42x | CN¥22.83 Million | CN¥54.69 Million | CN¥22.83 Million | ▲ +21.0% |
| 2009 | 0.34x | CN¥9.01 Million | CN¥26.11 Million | CN¥9.01 Million | ▼ -73.8% |
| 2008 | 1.32x | CN¥60.28 Million | CN¥45.75 Million | CN¥60.28 Million | ▲ +1219.7% |
| 2007 | 0.10x | CN¥4.90 Million | CN¥49.04 Million | CN¥4.90 Million | — |